BENITEC BIOPHARMA LIMITED (BLT)

Biotechnology, research and development.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
BLT	0.015	0%	0.014	0.015	0.016	0.016	0.015	2,946,534

BENITEC BIOPHARMA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	BLT
Securities	ASX Code, Security Description ------------------------------ BLT, Ordinary Fully Paid BLTO, Option Expiring 08-apr-2014 BLTOB, Option Expiring 31-dec-2013
Official Listing Date	17 February, 1997
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.benitec.com
Registered Office Address	Level 16, 356 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone	(02) 9555 6986
Head Office Fax	(03) 8678 1342
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Peter Francis (Non Exec. Chairman) Dr Peter French (CEO) Mr Mel Bridges (Non Exec. Director) Mr Kevin Buchi (Non Exec. Director) Dr John Chiplin (Non Exec. Director) Mr Iain Ross (Non Exec. Director)

Company Secretary	Mr Greg West
Principal Activities	Biotechnology, research and development.

BENITEC BIOPHARMA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
22/05/2013		PAIN PROGRAM PRESENTATION AT UK CONFERENCE	32	PDF
22/05/2013		BLT - Response to ASX price query	3	PDF
10/05/2013		UPDATE ON GENERAL MEETING TIMING	1	PDF
30/04/2013		Appendix 4C - quarterly	6	PDF
17/04/2013		HCV CLINICAL TRIAL APPLICATION SUBMITTED TO RAC	2	PDF
16/04/2013		UCSD SELECTED AS SITE FOR HCV PHASE I II TRIALS	2	PDF
15/04/2013		BENITEC LICENSEE SECURES ORHAN DRUG STATUS	1	PDF
12/04/2013		Initial Director's Interest Notice	2	PDF
11/04/2013		KEVIN BUCHI APPOINTED TO BENITEC BOARD	2	PDF
04/04/2013		PRECLINICAL EFFICACY IN LUNG CANCER MODEL	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	0.015	0%	0.016	0.015	2,946,534
21 May 2013	0.015	7.14%	0.016	0.015	10,903,545
20 May 2013	0.014	0%	0.014	0.014	300,000
17 May 2013	0.014	0%	0.015	0.014	600,000
16 May 2013	0.014	0%	0.014	0.014	1,293,000

* Volume of shares shown represents only those shares traded on ASX.

BENITEC BIOPHARMA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BLT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BLT

Warrants & Structured Products

No warrants & Structured Products are available over the security BLT

ASX CFDs

No Contracts For Differences are available over the security BLT

MyASX: Login | Sign up